Characterizing and targeting inflammation in COVID-19 using a rhesus macaque model of SARS-CoV-2 infection

Botanicals As A Source Of Novel Therapeutics For Infectious Diseases

Discovery of SARS-CoV-2 Antivirals from Zoonotic Peptides and Repurposed Drugs

Regulation of Leukocyte Inflammation by Small Particles Including Extracellular Vesicles and Viruses

Molecular Interactions between SARS-CoV-2 SPIKE protein and host targets

Distinct Roles for tissue-resident versus tissue-recruited macrophages in antiviral immunity